The Optometry Educational Dinner Updates in Primary Eyecare is brought to you by The Layton Vision Foundation (LVF) and the LVF Ophthalmology Research Centre.

Now into it's third year, book your tickets now for our first Optometry Educational Dinner in 2024.

With all our educational dinners, we go through the rigorous process of getting the CPD Activity approved for OA Institute of Excellence Quality Assurance by Optometry Australia for Continuing Professional Development (CPD) points. This event , that includes clinical, therapeutic and interactive points.

Please note the Registration Desk will be open from 6.30pm with official proceedings set to commence at 7pm. We plan to wrap up and close by 9pm.

About the Topic:

Progress in medical retinal disease diagnosis and treatments in the last two decades have astounded clinicians, with several previously untreatable conditions routinely now being associated with good long-term outcomes when treated in subspecialty practices. Recent advances are less well known and many can be applied cheaply and effectively into optometric practice. Examples include affordable full colour widefield imaging devices, FDA approved web based AI diagnostic tests for diabetic retinopathy with better accuracy than most experts, automated tools for macular degeneration prognosis and others showing efficacy for general retinal disease diagnosis and referral triaging. The need to reduce the treatment burden on patients with exudative and inflammatory disease continues to be a priority, and longer lasting anti-VEGF agents, sustained release implants and treatment approaches like gene therapy are either in use in the clinic or are being assessed by regulatory agencies. The availability of effective dry macular degeneration treatment will change the medical retina landscape forever this year and the latest information on these new agents will be presented. Finally, an update of new systemic therapies for the diseases which cause most medical retina disease will be covered.

Our Presenter - Professor Christopher Layton:

Professor Christopher Layton (Dr Chris) is a private Clinical Ophthalmologist, Rhodes Scholar and a national leader in innovative ophthalmology. His expertise is in macular disease, lens surgery and minimally invasive glaucoma interventions. He completed optometry at QUT, ophthalmology in Queensland, Oxford and London, subspecialty training in retinal disease at the Royal Brisbane Hospital and holds a PhD in diabetic retinopathy from Oxford University. Professor Layton is a Rhodes Scholar and founding director of the LVF Ophthalmology Research Centre. He is also CEO of Ocugene, a Queensland based biotech start-up which is commercialising his gene therapy technology targeting macular degeneration, uveitis and choroidal melanoma.

Sponsorship

This event is proudly sponsored by Bayer Australia Limited, in conjunction with the Layton Vision Foundation.

Our Optometry Educational Dinners are well attended and the last dinner attracted a wait list. Sponsoring our educational event can increase brand recognition before, during and after the actual event by giving your company exposure to new audiences and can provide attendees with a unique experience that fosters trust and credibility. Please follow this link to read more.

Register today so you don't miss out on your place, as it is limited to 60 places. If you have any questions or query, please contact our Brand Manager on admin@lvfeyecentre.org.au